STATE OF MINNESOTA SEVENTEENTH MEETING
HOUSE OF REPRESENTATIVES NINETY-THIRD SESSION
HEALTH FINANCE AND POLICY COMMITTEE
MINUTES
Representative Liebling, Chair of the Committee, called the meeting to order at 10:30 A.M. on March 2, 2023 in Room 5 of the State Office Building.
The Committee Legislative Assistant noted the roll.
Members present:
LIEBLING, Tina, Chair
BIERMAN, Robert, Vice-Chair
SCHOMACKER, Joe, Minority Lead
ACOMB, Patty
BACKER, Jeff
BAHNER, Kristin
CARROLL, Ned
ELKINS, Steve
FISCHER, Peter
HEMMINGSEN-JAEGER, Amanda
HER, Kaohly Vang
KIEL, Debra
MURPHY, Tom
NADEAU, Danny
NEU BRINDLEY, Anne
PERRYMAN, Bernie
QUAM, Duane
REYER, Liz
SMITH, Andy
Members excused:
A quorum was present.
HF348 (Howard) FIRST ENGROSSMENT Cost-sharing limited for prescription drugs and related medical supplies to treat chronic disease.
Chair Liebling moved that HF349, First Engrossment, be re-referred to the Committee on State and Local Government Finance and Policy.
Representative Howard presented his bill.
Testifying:
1. Emily Hassenstab, RN, Diabetes Educator, Children's Minnesota
2. Matt Schafer, Director of Government Affairs, Medica, representing Minnesota Council of Health Plans
3. Sara Ginsberg, Advocate, #Insulin4all
Chair Liebling renewed her motion that HF348, First Engrossment, be re-referred to the Committee on State and Local Government Finance and Policy. THE MOTION PREVAILED.
HF544 (Freiberg) Pharmacy benefit manager and health carrier requirements related to clinician-administered drugs.
Chair Liebling moved that HF544 be re-referred to the Committee on Commerce Finance and Policy.
Chair Liebling moved the H0544A1 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.
Representative Freiberg presented his bill as amended.
Testifying:
1. Brenda Reinhardt, Business Office Manager, Retina Consultants of Minnesota
2. Molly Skifstad, Director, Infusion and Research Pharmacy Services, Essentia Health
3. Bentley Graves, Policy Director, Minnesota Chamber of Commerce
4. Margaret Reynolds, Senior Director of Government Affairs, Cigna
5. Alex Sommer, Government Affairs Principal, Prime Therapeutics
6. Peter Fjelstad, Director, State Regulatory and Legal Affairs, Pharmaceutical Care Management Association (PCMA)
7. Dan Endreson, Senior Director of Government Affairs, Minnesota Council of Health Plans
8. Nick Zerwas, Lobbyist, America's Health Insurance Plans (AHIP)
Representative Nadeau moved the H0544A2-1 Amendment. After discussion, he withdrew the amendment.
Representative Nadeau moved the H0544A3 Amendment. After discussion he withdrew the amendment.
Chair Liebling renewed her motion that HF544, as amended, be re-referred to the Committee on Commerce Finance and Policy.
At 11:45 A.M. Vice Chair Bierman assumed the gavel.
HF1752 (Liebling) Commissioner of human services directed to establish a prescription drug purchasing program, program authority and eligibility requirements specified, and report required.
Chair Liebling moved that HF1752 be laid over for possible inclusion in the Health Finance and Policy Committee bill.
Chair Liebling moved the H1752DE1 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.
Chair Liebling presented her bill as amended.
Testifying:
1. Luke Slindee, Pharmacist
2. John Hoeschen, Pharmacist and Owner, Saint Paul Corner Drug
3. Danny Ackert, Director of Government Relations, Minnesota Hospital Association
Chad Hope, Director, Division of Purchasing and Service Delivery, Minnesota Department of Human Services, responded to member questions.
Vice Chair Bierman laid over HF1572, as amended, for possible inclusion in the Committee bill.
At 12:16 P.M. Chair Liebling assumed the gavel.
HF1665 (Bierman) Minnesota's schedules of controlled substances modified.
Vice Chair Bierman moved that HF1665 be re-referred to the Committee on Public Safety Finance and Policy.
Vice Chair Bierman presented his bill.
Testifying:
1. Kurtis Hanna, Lobbyist, MN NORML
Vice Chair Bierman renewed his motion that HF1665 be re-referred to the Committee on Public Safety Finance and Policy. THE MOTION PREVAILED.
HF1711 (Elkins) Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.
Representative Elkins moved that HF1711 be re-referred to the Committee on Commerce Finance and Policy.
Representative Elkins presented his bill.
Testifying:
1. Bentley Graves, Policy Director, Minnesota Chamber of Commerce
2. Peter Fjelstad, Director, State Regulatory and Legal Affairs, PCMA
Representative Elkins renewed his motion the HF1711 be re-referred to the Committee on Commerce Finance and Policy. THE MOTION PREVAILED.
The meeting was adjourned at 12:31 P.M.
________________________________________________________
Representative Tina Liebling, Chair
________________________________________________________
Krysta Niedernhöfer, Committee Legislative Assistant